DOCU Forms Deep 50.9% Base in Stage 2 Uptrend; Awaiting Breakout above 85.01

DOCU daily stock chart with 10, 20, 50, 150 and 200-day moving averages, volume and RS line versus SPY, Stage 2 (Advancing), as of September 02, 2026 at 01:07 — CANSLIM Research

DocuSign (DOCU) is holding a Stage 2 uptrend with price above its rising 30-week moving average, though the current base is a deep 50.9% correction — a pattern with an elevated failure rate. The market is focused on the stock’s ability to reclaim its 85.01 pivot after a 36.2% run and shallow 2.4% pullback, which has formed a bull flag. Overall sentiment is constructive but cautious, as the setup lacks a confirmed VCP contraction sequence and awaits a decisive breakout.

As of 2026-09-01 · Close $64.69

Stage 2 (Advancing) — Price holding above a rising 30-week MA — uptrend intact (30-week MA 6-week slope: 2.05%)

⚠️ Faulty cup warning: the base is 50.9% deep (above the 38–40% threshold). A correction this deep leaves heavy overhead supply — trapped holders from higher prices are likely to sell into any rally, raising the failure rate of a breakout from this base.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.